Biotek-snakken
Aktiesnakken
Genmab
NOVO
TESLA
Zealand Pharma
Forsvarsaktier
Bavarian Nordic
Ennogie
Amerikanske aktier
Grønne Aktier
Biotek-snakken
Medico
Shipping
Vestas
AMBU
ExpreS2ion
Pharma
Politiksnakken
Banker og Finans
BITCOIN
Chemometec
Embla Medical
Laks
Smallcap og First North aktier
|
12/10 06:05 af Fandel |
Godmorgen...
|
|
|
11/10 07:07 af ProInvestorNEWS |
FDA Approves Genentech's Itovebi For Advanced Breast Cancer With PIK3CA Mutation (link)
|
|
|
11/10 06:03 af Fandel |
Godmorgen...
|
|
10/10 09:01 af exitnu |
Nordea höjer Genovis till köp (behåll), riktkurs 28 kronor
|
|
|
8/10 06:40 af ProInvestorNEWS |
Vincerx Reports Positive Initial Clinical Data From VIP943 Phase 1 Dose-Escalation Study (link)
|
|
|
8/10 06:18 af ProInvestorNEWS |
Indivior Announces FDA Grants Priority Review For SUBLOCADE Prior Approval Supplement (link)
|
|
|
8/10 06:16 af ProInvestorNEWS |
Gilead Sciences : Phase 3 Data Shows 96% Reduction In HIV Infections With Lenacapavir (link)
|
|
|
8/10 05:32 af Fandel |
Godmorgen...
|
|
|
7/10 09:01 af Bjæssing09 |
Nyt fra Saniona igen: (link)
|
|
|
4/10 08:45 af exitnu |
Ang. Genovis Insider Ownership: Der er 6 i alt som har købt eller lagt til inden for de sidste 6 måneder.
|
|
|
4/10 08:33 af exitnu |
Styrelseledamot i Genovis köper sina första aktier i bolaget - Steven Jordan har den 2 oktober köpt 5 010 aktier i bioteknikbolaget Genovis där han är styrelseledamot. Aktierna köptes till kursen 1,95 pund per aktie, vilket innebär en affär på 9 769,5 pund eller cirka 132 000 kronor. Det framgår av Finansinspektionens insynsregister. Enligt bolagets hemsida ägde han inga aktier tidigare. /Finwire Smallcap.
|
|
|
4/10 07:14 af ProInvestorNEWS |
Opdivo wins FDA label expansion in perioperative NSCLC (link)
|
|
|
4/10 07:04 af LP90 |
Godmorgen :-)
|
|
|
4/10 06:54 af Fandel |
Godmorgen...
|
|
|
3/10 09:17 af LP90 |
Godmorgen :-)
|
|
|
3/10 09:16 af ProInvestorNEWS |
Lundbeck indleder studie med kandidat mod sjælden øjensygdom (link)
|
|
|
3/10 08:46 af exitnu |
God morgen :-)
|
|
|
3/10 06:02 af Fandel |
Godmorgen...
|
|
|
1/10 08:55 af Bjæssing09 |
Saniona med nyheder: (link)
|
|
|
1/10 07:14 af ProInvestorNEWS |
Roche upbeat on obesity as acquisitions continue pipeline refresh (link)
|
|
|
1/10 06:31 af ProInvestorNEWS |
Why Viking Therapeutics Stock Topped the Market Today (link)
|
|
|
29/9 15:08 af Stroka |
I
s Viking Therapeutics Stock a Buy? (link)
|
|
|
29/9 07:04 af ProInvestorNEWS |
Enliven Therapeutics Updates Positive Phase 1 Data For ELVN-001 In Chronic Myeloid Leukemia Patients (link)
|
|
|
27/9 15:56 af ProInvestorNEWS |
Lundbeck vil forstå kronisk nervesygdom bedre med nyt studie (link)
|
|
| ||
|
|
27/9 07:20 af ProInvestorNEWS |
FDA panel votes against PD-1s in gastric, oesophageal cancers with low biomarker expression (link)
|
|
|
27/9 07:19 af ProInvestorNEWS |
AstraZeneca scores wider US lung cancer label for Tagrisso (link)
|
|
|
27/9 07:18 af ProInvestorNEWS |
AbbVie sets sights on clinical hat trick for Cerevel Parkinson's drug (link)
|
|
|
27/9 06:42 af ProInvestorNEWS |
SEC Announces $40 Mln Settlement With Cassava Sciences Over Misleading Alzheimer's Trial Statements (link)
|
|
|
27/9 06:33 af ProInvestorNEWS |
Evaxion sælger rettigheder til to vaccinekandidater for potentielt milliardbeløb
Det er partneren MSD, som køber retten til en vaccinekandidat mod gonoré og et ikke-offentliggjort infektionsmiddel. (Medwatch abonnement) (link)
|
|
|
27/9 06:32 af ProInvestorNEWS |
Evaxion significantly expands vaccine development collaboration with MSD (link)
|
|
|
27/9 06:19 af ProInvestorNEWS |
Bristol Myers Squibb's COBENFY Gains FDA Approval For Adult Schizophrenia Treatment (link)
|
|
|
27/9 06:18 af ProInvestorNEWS |
Biomea Fusion : FDA Lifts Clinical Hold On BMF-219 For Type 1 And Type 2 Diabetes Trials; Stock Up (link)
|
|
|
27/9 06:17 af ProInvestorNEWS |
Travere Therapeutics Pauses Enrollment In Phase 3 Study Of Pegtibatinase For Manufacturing Scale-Up (link)
|
|
|
27/9 05:36 af Fandel |
Godmorgen...
|
|
|
25/9 08:20 af exitnu |
SEB inleder bevakning på Genovis med köp och riktkurs 30 kronor - BN /Finwire
|
|
|
23/9 15:30 af exitnu |
Genovis Launches FabRICATOR® Xtra: Next-Generation Enzyme for Future Antibody Therapeutics
(link)
|
|
|
23/9 07:18 af ProInvestorNEWS |
Sanofi gears up to seek approval of BTK inhibitor tolebrutinib in MS (link)
|
|
|
23/9 07:16 af ProInvestorNEWS |
FDA greenlights Sanofi's Sarclisa in frontline multiple myeloma (link)
|
|
|
23/9 05:28 af Fandel |
Godmorgen...
|
|
|
21/9 08:25 af ProInvestorNEWS |
FDA Approves Zevra Therapeutics' MIPLYFFA For Treatment Of Niemann-Pick Disease Type C (link)
|
|
|
21/9 05:32 af Fandel |
Godmorgen...
|
|
|
20/9 06:01 af ProInvestorNEWS |
Ascendis Pharma Prices Public Offering Of 2 Mln ADSs At $150.00/ADS (link)
|
|
|
20/9 06:00 af ProInvestorNEWS |
Tectonic Therapeutics Announces Positive Phase 1a Results For TX45 In Treating Group 2 PH-HFpEF (link)
|
|
|
20/9 06:00 af ProInvestorNEWS |
ELAN : FDA Oks Zenrelia, Once-Daily Oral JAK Inhibitor For Dogs With Allergic And Atopic Dermatitis (link)
|
|
19/9 18:37 af Henrikhot |
(link) Saniona Receives Regulatory Approval for SAN711 Biomarker Study
|
|
|
19/9 18:34 af Henrikhot |
Saniona kommenterar godkännandet att inleda epilepsistudie (link)
|
|
|
19/9 09:39 af exitnu |
"Handel i betalda tecknade units (”BTU”): 20 augusti – 20 september 2024."
|
|
|
19/9 09:38 af exitnu |
Ascelia Pharma BTU: sidste handelsdag nu på fredag :-)
|
|
|
19/9 06:03 af ProInvestorNEWS |
Incyte: Phase 2 Trial Results Of Niktimvo In Chronic Graft-Versus-Host Disease Meet Primary Goal (link)
|
|
|
17/9 06:11 af ProInvestorNEWS |
I-Mab Reports Promising Results From Phase 1 Study Of Givastomig In Gastric Cance (link)
|